Weeks to Hours: Accelerating Drug Discovery with AIP | Novartis at AIPCon 8

Novartis' New Breast Cancer Drug | Kisqali® | N18S | CNBC TV18

Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm

'GAME-CHANGER': Drug Giant Novartis Develops Life-Saving New Anti-Malaria Medicine

We belong here | Matus' story

Novartis leads cancer breakthrough with radioligand therapy

Drug discovery and development process

How does Novartis create value for stakeholders and society?

Novartis transformation into a pure-play Innovative Medicines company